NO991910L - Antiherpes farmas°ytisk sammensetning inneholdende acyklovir for topiske applikatorer - Google Patents

Antiherpes farmas°ytisk sammensetning inneholdende acyklovir for topiske applikatorer

Info

Publication number
NO991910L
NO991910L NO991910A NO991910A NO991910L NO 991910 L NO991910 L NO 991910L NO 991910 A NO991910 A NO 991910A NO 991910 A NO991910 A NO 991910A NO 991910 L NO991910 L NO 991910L
Authority
NO
Norway
Prior art keywords
antiherpes
pharmaceutical composition
composition containing
containing acyclovir
topical applicators
Prior art date
Application number
NO991910A
Other languages
English (en)
Norwegian (no)
Other versions
NO991910D0 (no
Inventor
Giancarlo Santus
Roberto Golzi
Antonio Garavaglia
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of NO991910D0 publication Critical patent/NO991910D0/no
Publication of NO991910L publication Critical patent/NO991910L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO991910A 1996-10-31 1999-04-21 Antiherpes farmas°ytisk sammensetning inneholdende acyklovir for topiske applikatorer NO991910L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI002258A IT1287114B1 (it) 1996-10-31 1996-10-31 Composizioni farmaceutiche antierpetiche per applicatori topici, contenenti aciclovir
PCT/EP1997/006022 WO1998018472A1 (fr) 1996-10-31 1997-10-31 Compositions pharmaceutiques antiherpetiques contenant de l'acyclovir pour applicateurs locaux

Publications (2)

Publication Number Publication Date
NO991910D0 NO991910D0 (no) 1999-04-21
NO991910L true NO991910L (no) 1999-06-21

Family

ID=11375126

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991910A NO991910L (no) 1996-10-31 1999-04-21 Antiherpes farmas°ytisk sammensetning inneholdende acyklovir for topiske applikatorer

Country Status (13)

Country Link
EP (1) EP0948332B1 (fr)
JP (1) JP2001503404A (fr)
KR (1) KR20000052678A (fr)
CN (1) CN1235547A (fr)
AT (1) ATE248597T1 (fr)
AU (1) AU724741B2 (fr)
BR (1) BR9712610A (fr)
CA (1) CA2270254A1 (fr)
DE (1) DE69724647D1 (fr)
IT (1) IT1287114B1 (fr)
NO (1) NO991910L (fr)
NZ (1) NZ335685A (fr)
WO (1) WO1998018472A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
AU3853800A (en) * 1999-01-11 2000-08-01 Ahmet Degirmenci Pharmaceutical forms and methods for penetration continuity
GB9902227D0 (en) * 1999-02-01 1999-03-24 Cipla Limited Pharmaceutical composition for topical administration
AU2004202929B2 (en) * 1999-09-22 2006-11-23 B. Ron Johnson Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
US6967023B1 (en) 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
US6475526B1 (en) * 2001-06-05 2002-11-05 Jeffrey B. Smith Zinc containing compositions for anti-viral use
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20040091539A1 (en) * 2002-11-13 2004-05-13 Ake Lindahl Dermastick thickened ointment
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
CN101123948A (zh) * 2005-02-17 2008-02-13 千寿制药株式会社 眼科用固体外用药剂
CA2619393A1 (fr) 2005-08-17 2007-02-22 Charles Tadlock Systeme d'administration de coupe-faim
JP4013076B2 (ja) * 2005-09-30 2007-11-28 小林製薬株式会社 固形状の外用医薬組成物
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (fr) 2007-12-07 2009-06-11 Foamix Ltd. Porteurs, formulations, procédés pour formuler des agents actifs instables pour application externe et utilisations associées
DE102007061897A1 (de) * 2007-12-20 2009-06-25 Matthias Dr. Hempel Paraffinfreier Lippenpflegestift
WO2010125470A2 (fr) 2009-04-28 2010-11-04 Foamix Ltd. Véhicule moussant et compositions pharmaceutiques comportant des solvants polaires aprotiques et leurs utilisations
CA2769677A1 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes a base d'agents non tensioactifs non polymeres, mousses legeres, et leurs utilisations
WO2011013009A2 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes non tensioactives, mousses légères, et leurs utilisations
WO2011064631A1 (fr) 2009-10-02 2011-06-03 Foamix Ltd. Compositions moussantes dépourvues d'agent tensioactif et d'eau et mousses cassables et leurs utilisations
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
ITMI20111747A1 (it) 2011-09-28 2013-03-29 Fidia Farmaceutici Composizioni farmaceutiche topiche comprendenti aciclovir
CN103751100B (zh) * 2013-11-28 2015-09-16 郑州韩都药业集团有限公司 一种阿昔洛韦乳膏
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
GB201819418D0 (en) * 2018-11-29 2019-01-16 Daniel Calladine Ltd Anti-viral compositions
CN114302707A (zh) * 2019-06-14 2022-04-08 普洛拉治疗公司 局部阿昔洛韦制剂及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9114939D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
DZ1966A1 (fr) * 1995-02-06 2002-10-15 Astra Ab Combinaison pharmaceutique nouvelle.

Also Published As

Publication number Publication date
NO991910D0 (no) 1999-04-21
ATE248597T1 (de) 2003-09-15
EP0948332B1 (fr) 2003-09-03
IT1287114B1 (it) 1998-08-04
BR9712610A (pt) 1999-12-21
CA2270254A1 (fr) 1998-05-07
EP0948332A1 (fr) 1999-10-13
NZ335685A (en) 2000-03-27
ITMI962258A1 (it) 1998-05-01
CN1235547A (zh) 1999-11-17
AU724741B2 (en) 2000-09-28
AU6907898A (en) 1998-05-22
KR20000052678A (ko) 2000-08-25
DE69724647D1 (de) 2003-10-09
JP2001503404A (ja) 2001-03-13
WO1998018472A1 (fr) 1998-05-07

Similar Documents

Publication Publication Date Title
NO991910L (no) Antiherpes farmas°ytisk sammensetning inneholdende acyklovir for topiske applikatorer
PT671161E (pt) Ectoina e derivados de ectoina como distribuidor de humidade em produtos cosmeticos
ES2119800T3 (es) Mejora de la penetracion de formulaciones de aplicacion topica.
MY135988A (en) Additive for improving the water resistance of cosmetic or dermatological formulations
MX9304710A (es) Composicion farmaceutica y/o cosmetica y su uso.
NZ504076A (en) A topical formulation which induces a minimal systemic effect when applied to the skin, the topical formulation comprising an immunosuppressive macrolide selected from sirolimus, FK506 and SDZ ASM 981 and a permeation modulator for the treatment of a dermatological condition
SE8804629D0 (sv) New therapeutically active compounds
GB9626513D0 (en) A pharmaceutical composition
EP0824915A3 (fr) Préparation de glycoglycerolipides, leur utilisation comme agents tensio-actifs et compositions cosmétiques ou dermatologiques les contenant
AU4775099A (en) Trichological lotion for topical use
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
PH15114A (en) Propanone derivatives,and pharmaceutical composition containing this derivative as active ingredient
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
ATE173627T1 (de) Medizinische zusammensetzung
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
IT1253431B (it) Preparati farmaceutici per uso topico destinati al trattamento della psoriasi e della dermatite atopica
FI955403A0 (fi) Valeltavia koostumuksia, jotka sisältävät polymeerimateriaalia, glykoleja ja glyseridejä
IE781032L (en) Pharmaceutical compositions
DK0402933T3 (da) Anvendelse af fugtig sucralfatgel som bærer for medikamenter med topisk virkning og for kosmetik
DK0464297T3 (da) Komplekser af neolignanderivater med phospholipider, anvendelsen deraf samt farmaceutiske og kosmetiske formuleringer indeholdende disse
AU3946197A (en) Cosmetic, dermatological and pharmaceutical use of a terminalia catappa extract
GR1001511B (el) Στεροειδείς συν?έσεις.
EP1269978A3 (fr) Utilisation de dérivés de la bis-resorcinyl triazine dans des préparations cosmétiques ou dermatologiques
NO970178D0 (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
IT1233198B (it) Derivati di benzilidene ciclanoni,procedimento per la loro preparazione, loro impiego come agenti anti- ossidanti, composizioni cosmetiche e farmaceutiche che li contengono

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application